Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikiProjectMed
Search

PTI-2

From WikiProjectMed
Chemical compound
Pharmaceutical compound
PTI-2
Legal status
Legal status
Identifiers
  • N-(2-methoxyethyl)-N-((2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl)methyl)propan-2-amine
CAS Number
PubChemCID
ChemSpider
UNII
Chemical and physical data
FormulaC23H33N3OS
Molar mass399.60 g·mol−1
3D model (JSmol)
  • CCCCCN1C=C(C2=CC=CC=C21)C3=NC(CN(C(C)C)CCOC)=CS3
  • InChI=1S/C23H33N3OS/c1-5-6-9-12-26-16-21(20-10-7-8-11-22(20)26)23-24-19(17-28-23)15-25(18(2)3)13-14-27-4/h7-8,10-11,16-18H,5-6,9,12-15H2,1-4H3
  • Key:PSAKYYVEVVAWJL-UHFFFAOYSA-N

PTI-2 (SGT-49) is anindole-basedsynthetic cannabinoid.[1] It is one of fewsynthetic cannabinoids containing athiazole group and is closely related toPTI-1. These compounds may be viewed as simplified analogues of indole-3-heterocycle compounds originally developed byOrganon and subsequently further researched byMerck.[2][3][4]

See also

References

  1. ↑"PTI-2". Cayman Chemical. Retrieved8 July 2015.
  2. ↑US 7700634,Adam-Worrall J, Morrison AJ, Wishart G, Kiyoi T, McArthur DR,"(Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor.",issued 20 April 2010, assigned to Organon NV 
  3. ↑US 7763732,Paul David Ratcliffe PD, Adam-Worrall J, Morrison AJ, Francis SJ, Kiyoi T,"Indole Derivatives",issued 27 July 2010, assigned to Organon NV 
  4. ↑Kiyoi T, Adam JM, Clark JK, Davies K, Easson AM, Edwards D, et al. (March 2011). "Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists".Bioorganic & Medicinal Chemistry Letters.21 (6):1748–53.doi:10.1016/j.bmcl.2011.01.082.PMID 21316962.
Phytocannabinoids
(comparison)
Cannabibutols
Cannabichromenes
Cannabicyclols
Cannabidiols
Cannabielsoins
Cannabigerols
Cannabiphorols
Cannabinols
Cannabitriols
Cannabivarins
Delta-3-tetrahydrocannabinols
Delta-4-tetrahydrocannabinols
Delta-7-tetrahydrocannabinols
Delta-8-tetrahydrocannabinols
Delta-9-tetrahydrocannabinols
Delta-10-Tetrahydrocannabinols
Delta-11-Tetrahydrocannabinols
Miscellaneous cannabinoids
Active metabolites
Endocannabinoids
Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Classical cannabinoids
(dibenzopyrans)
Non-classical
cannabinoids
Adamantoylindoles
Benzimidazoles
Benzoylindoles
Cyclohexylphenols
Eicosanoids
Indazole-3-
carboxamides
Indole-3-carboxamides
Indole-3-carboxylates
Naphthoylindazoles
Naphthoylindoles
Naphthoylpyrroles
Naphthylmethylindenes
Naphthylmethylindoles
Phenylacetylindoles
Pyrazolecarboxamides
Tetramethylcyclo-
propanoylindazoles
Tetramethylcyclo-
propanoylindoles
Others
AllostericCBRTooltip Cannabinoid receptorligands
Endocannabinoid
enhancers
(inactivation inhibitors)
Anticannabinoids
(antagonists/inverse
agonists/antibodies)
Receptor
(ligands)
CB1Tooltip Cannabinoid receptor type 1
Agonists
(abridged,
full list)
Inverse agonists
Antagonists
CB2Tooltip Cannabinoid receptor type 2
Agonists
Antagonists
NAGly
(GPR18)
Agonists
Antagonists
GPR55
Agonists
Antagonists
GPR119
Agonists
Transporter
(modulators)
eCBTsTooltip Endocannabinoid transporter
Enzyme
(modulators)
FAAHTooltip Fatty acid amide hydrolase
MAGL
ABHD6
ABHD12
Others
  • Others:2-PG(directly potentiates activity of 2-AG at CB1 receptor)
  • ARN-272(FAAH-like anandamide transporter inhibitor)
See also
Receptor/signaling modulators
Cannabinoids (cannabinoids by structure)
Stub icon

Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://mdwiki.org/w/index.php?title=PTI-2&oldid=1298229339"
[8]ページ先頭
©2009-2025 Movatter.jp